The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Marco BertolottiMarina Del Puppo

Abstract

Alterations of cholesterol homeostasis represent important risk factors for atherosclerosis and cardiovascular disease. Different clinical-experimental approaches have been devised to study the metabolism of cholesterol and particularly the synthesis of bile acids, its main catabolic products. Most evidence in humans has derived from studies utilizing the administration of labeled sterols; these have several advantages over in vitro assay of enzyme activity and expression, requiring an invasive procedure such as a liver biopsy, or the determination of fecal sterols, which is cumbersome and not commonly available. Pioneering evidence with administration of radioactive sterol derivatives has allowed to characterize the alterations of cholesterol metabolism and degradation in different situations, including spontaneous disease conditions, aging, and drug treatment. Along with the classical isotope dilution methodology, other approaches were proposed, among which isotope release following radioactive substrate administration. More recently, stable isotope studies have allowed to overcome radioactivity exposure. Isotope enrichment studies during tracer infusion has allowed to characterize changes in the degradation of cholesterol vi...Continue Reading

References

Jan 1, 1979·Scandinavian Journal of Gastroenterology·E Andersén
Aug 1, 1978·The American Journal of Digestive Diseases·M P de LeonN Carulli
May 1, 1977·The Journal of Clinical Investigation·E A Shaffer, D M Small
Jun 16, 1977·The New England Journal of Medicine·L J Bennion, S M Grundy
Oct 1, 1975·The Journal of Clinical Investigation·L J Bennion, S M Grundy
Dec 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·M BicíkováL Stárka
Sep 1, 1992·The Journal of Clinical Investigation·F BerrG Paumgartner
Apr 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·U BeuersG Paumgartner
May 26, 1992·Biochemistry·D W Russell, K D Setchell
Jun 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G MazzellaE Roda
Dec 1, 1991·The Biochemical Journal·S DuelandR A Davis
Mar 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Z R VlahcevicP B Hylemon
Aug 15, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·J FujiyamaM Osame
Nov 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M BertolottiN Carulli
Dec 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A CrosignaniK D Setchell
May 1, 1989·The Journal of Clinical Investigation·F BerrG Paumgartner
Jun 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J PauletzkiG Paumgartner
Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P A Pooler, W C Duane
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·B AngelinJ D Brunzell
Apr 1, 1986·Gastroenterology·P LoriaM Montanari
Aug 1, 1985·The New England Journal of Medicine·K EinarssonB Angelin
Nov 1, 1973·The Journal of Clinical Investigation·R C DanzingerL J Schoenfield
Mar 1, 1973·The New England Journal of Medicine·J B WatkinsR Lester
Aug 1, 1973·The Journal of Clinical Investigation·S H Quarfordt, M F Greenfield
Dec 6, 1973·The New England Journal of Medicine·H R AlmondL Swell
Feb 1, 1983·European Journal of Clinical Investigation·B AngelinB Leijd
Dec 1, 1983·The Journal of Clinical Investigation·W C DuaneJ C Behrens
Dec 1, 1980·European Journal of Clinical Investigation·A W HuijbregtsS D Van der Werf
Sep 15, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·T A Miettinen

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Cell Aging

This feed focuses on cellular aging with emphasis on mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.